Evidence map›Paper›PMID 35013702›Full record

ArticleJournal of big data2022

Machine learning approaches in Covid-19 severity risk prediction in Morocco.

Mariam Laatifi, Samira Douzi, Abdelaziz Bouklouz, Hind Ezzine, Jaafar Jaafari, Younes Zaid, Bouabid El Ouahidi, Mariam Naciri

Abstract read
In one paragraph

Article in Journal of big data, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mariam LaatifiDepartment of Biology, Faculty of Sciences, Mohammed V University, Rabat, Morocco.
Samira DouziFMPR, University Mohammed V, Rabat, Morocco.
Abdelaziz BouklouzLaboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Rabat, Morocco.
Hind EzzineDepartment of Biology, Faculty of Sciences, Mohammed V University, Rabat, Morocco.
Jaafar JaafariFSTM, University Hassan II, Casablanca, Morocco.ORCID 0000-0001-8825-5427
Younes ZaidDepartment of Biology, Faculty of Sciences, Mohammed V University, Rabat, Morocco.
Bouabid El OuahidiDepartment of Computer Science, Faculty of Sciences, Mohammed V University, Rabat, Morocco.
Mariam NaciriDepartment of Biology, Faculty of Sciences, Mohammed V University, Rabat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study is to develop and test machine learning-based models for COVID-19 severity prediction. COVID-19 test samples from 337 COVID-19 positive patients at Cheikh Zaid Hospital were grouped according to the severity of their illness. Ours is the first study to estimate illness severity by combining biological and non-biological data from patients with COVID-19. Moreover the use of ML for therapeutic purposes in Morocco is currently restricted, and ours is the first study to investigate the severity of COVID-19. When data analysis approaches were used to uncover patterns and essential characteristics in the data, C-reactive protein, platelets, and D-dimers were determined to be the most associated to COVID-19 severity prediction. In this research, many data reduction algorithms were used, and Machine Learning models were trained to predict the severity of sickness using patient data. A new feature engineering method based on topological data analysis called Uniform Manifold Approximation and Projection (UMAP) shown that it achieves better results. It has 100% accuracy, specificity, sensitivity, and ROC curve in conducting a prognostic prediction using different machine learning classifiers such as X_GBoost, AdaBoost, Random Forest, and ExtraTrees. The proposed approach aims to assist hospitals and medical facilities in determining who should be seen first and who has a higher priority for admission to the hospital.

Indexed as

COVID-19Data analysisFeature reductionFeature selectionMachine learningSeverity

Identifiers

PMID35013702
PMCPMC8733912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.